BONESUPPORT CEO Emil Billbäck Shares Insights About Cerament G, the New Bone Void Filler Launching in the US
XTalks
JUNE 1, 2022
BONESUPPORT received market authorization from the FDA for Cerament G, the first and only bone graft with antibiotic elution that is approved for the US market. Osteomyelitis is a bone infection caused by fungi or bacteria. BONESUPPORT is an orthobiologics company focused on the management of bone injuries.
98 
Let's personalize your content